Semaglutide Market

The semaglutide market consists of drugs used for treating type 2 diabetes and chronic weight management by mimicking a hormone that regulates blood sugar and appetite. The primary customers are patients with these metabolic diseases, who access the medication via prescription. Key growth drivers include the rising global incidence of diabetes and obesity, the drug's dual effectiveness in managing both conditions, and the development of a more convenient oral version which expands patient accessibility.